Adverse effects after HAART initiation in resource-limited settings: A prospective study from Mysore, India

Journal of Infection in Developing Countries

Volumn 4, Issue 11, 2010, Pages 750-753

  Srirangaraj, Sreenivasan ^a,b   Venkatesha, Dasegowda ^a  

^a MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Adverse effects; HAART; Laboratory monitoring

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG ERUPTION; FEMALE; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERIPHERAL NEUROPATHY; SIDE EFFECT; TUBERCULOSIS;

EID: 78650356473     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.934     Document Type: Article

References (8)

1. National Guidelines for Implementation of anti retroviral therapy (ART) draft version. (2004) New Delhi: National AIDS Control Organization.
2. Mahajan AP, Hogan JW, Snyder B, Kumaraswamy N, Mehta K, Solomon S, Carpenter CCJ, Mayer KH, Flanigan TP (2004) Changes in Total Lymphocyte Count as a Surrogate for Changes in CD4 Count Following Initiation of HAART: Implications for Monitoring in Resource-Limited Settings. J Acquir Immune Defic Syndr 36: 567-575.
3. Pattanapanyasat K and Thakar MR (2005) CD4+T cell count as a tool to monitor HIV progression and anti-retroviral therapy. Indian J Med Res 121: 539-549.
4. Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CCJ, Solomon S, Mayer KH (2006) Reasons for Modification of Generic Highly Active Antiretroviral Therapeutic Regimens Among Patients in Southern India. J Acquir Immune Defic Syndr 41: 53-58.
5. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Pierre SK, Wright PF, Gulick R, Johnson WD, Pape JW, Fitzgerald DW (2005) Antiretroviral therapy in a thousand patients with AIDS in Haiti. NEJM353: 2325-2334.
6. Laurent C, Kouanfack C, Shiro SK, Nkoue N, Bourgeois A, Calmy A (2004) Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1 infected adults in Cameroon: open-label multicentre trial. Lancet 364: 29-34.
7. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach (2006) Geneva: World Health Organization.
8. National Guidelines for Implementation of anti retroviral therapy (ART) draft version. (2004) New Delhi: National AIDS Control Organization.